Advanced mechanisms in drug delivery

Impact and assessment of modern mechanisms in drug delivery systems

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Drug delivery refers to the efficient transport of an active pharmaceutical compound to provide a therapeutic effect that is required by the human body. Drug delivery systems are extremely crucial for patients who require regular doses of medication through the prescribed route of administration. The research study deals with drug delivery mechanisms that are categorized as existing and emerging carriers or technologies that deliver the therapeutic at the target site. Drug delivery industry has witnessed a sea change as majority of the conventional carriers such as polymeric micelles, dendrimers and niosomes are being slowly replaced by emerging approaches such as cyclodextrins, microemulsions, hydrogels, etc. due to their ability to improve drug solubility and bioavailability which help the drug cope with the hostile nature of the gastro-intestinal tract. The research study covers the stakeholder analysis of the key players in the drug delivery industry, particularly the drug delivery technology developers and pharmaceutical manufacturers and also assesses the technology adoption with respect to these mechanisms. Finally, opportunity evaluation has been conducted to understand the scope of future mechanisms in drug delivery with the help of a technology roadmap, partnerships model that assess the partnerships based on technology licensing, product development and distribution and the IP landscape that evaluate the level of interest of existing and emerging technologies amongst key stakeholders.

Table of Contents

Executive SummaryResearch Process MethodologyResearch Methodology (continued)Key FindingsSneak Preview into Drug DeliveryOverviewTechnology AssessmentTechnology RoadmapPolymeric MicellesPolymeric MicellesNiosomesPhosphorous AcidsStarch-Based CarrierStarch-Based Carrier (continued)LiposomesLiposomes (continued)MicroemulsionsMicroemulsions (continued)Magnetic Nanoparticles (MNPs)/ Mesoporous silica systems (MSPs)Magnetic Nanoparticles (MNPs)Biodegradable Microstructure Patch TechnologyBiodegradable Microstructure Patch Technology (continued)CyclodextrinsCyclodextrins (continued)Functional Micelles/Biomimetic Microvesicles/NanosomesFunctional Micelles/Biomimetic Microvesicles/Nanosomes (continued)Functional Micelles/Biomimetic Microvesicles/NanosomesRecent Innovations (continued)Supramolecular ArchitecturesSupramolecular ArchitecturesMicroencapsulated Phase Change MaterialsMicroencapsulated Phase Change Materials (continued)Fluid Crystal Nanoparticles/Cholesteric Liquid Crystal/Liquid Crystalline DendrimersFluid Crystal NanoparticlesDiffusion of Innovations and Needs AssessmentTechnology LandscapeDemand side AnalysisStakeholder Analysis of Key ParticipantsStakeholder AnalysisStakeholder Analysis (continued)Stakeholder analysis (continued)SWOT analysis of Key ParticipantsFunding Assessment of Key ParticipantsFunding AssessmentFunding Assessment (continued)Opportunity EvaluationEmerging Technology Roadmap Emerging Technology Roadmap (continued) Assessment of PartnershipsAssessment of Partnerships (continued)Assessment of Partnerships (continued)Assessment of Partnerships (continued)Assessment of Partnerships (continued)Assessment of Partnerships (continued)Technology Management StrategiesIP LandscapePatent scenarioPatent scenario (continued)Key Contacts and PatentsKey contactsGlobal PatentsGlobal Patents (continued)Legal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Related Research

Release Date : 1-Jul-2016

Region : Europe

Release Date : 24-Jun-16

Region : Europe

Release Date : 4-May-2016

Region : Europe

Release Date : 19-Apr-16

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.